Publications by authors named "Angela Sinn"

Claim this Profile
I
In Vitro Evaluation of CYP-Mediated Metabolism of Fezolinetant and Pharmacokinetic Interaction Between Fezolinetant and Fluvoxamine in Healthy Postmenopausal Smokers and Nonsmokers.
Megumi Iwai, Jace Nielsen, Mayuko Miyagawa, Melanie Patton, Peter L Bonate, Angela Sinn

J Clin Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.
Maria B N Gabe, Rainard Fuhr, Angela Sinn, Astrid Eliasen, Kasper K Berthelsen

Diabetes Obes Metab· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double blind, single dose, comparative study of the pharmacokinetics, safety and immunogenicity of MB02 (bevacizumab biosimilar) and reference bevacizumab in healthy male volunteers.
Angela Sinn, Fernanda García-Alvarado, Veronica Gonzalez, Camino Huerga, Felicitas Bullo

Br J Clin Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial.
Martin Kaul, Peter End, Maciej Cabanski, Carole Schuhler, Annamaria Jakab, Angela Sinn

Clin Transl Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection.
Monika Gajewska, Lars Blumenstein, Alexandros Kourentas, Martin Mueller-Zsigmondy, Sebastien Lorenzo, Angela Sinn

AAPS J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.
Niels-Peter Becker, Annekathrin Haberland, Katrin Wenzel, Peter Göttel, Gerd Wallukat, Angela Sinn

Clin Drug Investig· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans.
Hanna Davideit, Susanne Becker, Johannes Müller, Niels-Peter Becker, Peter Göttel, Angela Sinn

Eur J Drug Metab Pharmacokinet· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis